Masimo's Momentum Keeps Going in Q3 With Solid Earnings Growth
If a 41% year-to-date gain sounds good to you, you'll probably like Masimo (NASDAQ: MASI). That's what the medical device stock has delivered to investors so far in 2019, trouncing the performance for most healthcare stocks.
But that big gain came before Masimo announced its third-quarter results after the market closed on Wednesday. And those results looked very good. Here are the highlights from the company's Q3 update.
Image source: Masimo.
Source Fool.com
